SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Economics of the Pharmaceutical Industry
16 references·7 citing·45 second hop
Economics of the Pharmaceutical Industry (2018)Economics of the Pharmaceutical IndustryPricing in the Market for Anticancer Drugs (2015)Pricing in the Market for Ant…Do Firms Underinvest in Long-Term Research? Evidence from Cancer Clinical Trials (2015)Do Firms Underinvest in Long-…The cost of biopharmaceutical R&D: is biotech different? (2007)The cost of biopharmaceutical…Estimating The Cost Of New Drug Development: Is It Really $802 Million? (2006)Estimating The Cost Of New Dr…Static and Dynamic Effects of Health Policy: Evidence from the Vaccine Industry (2004)Static and Dynamic Effects of…Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry (2004)Market Size in Innovation: Th…Willingness to Pay for a Quality-adjusted Life Year (2000)Willingness to Pay for a Qual…The Role of Firm Size in Bilateral Bargaining: A Study of the Cable Television Industry (1999)The Role of Firm Size in Bila…Scale, Scope, and Spillovers: The Determinants of Research Productivity in Drug Discovery (1996)Scale, Scope, and Spillovers:…On the Division of Profit in Sequential Innovation (1995)On the Division of Profit in …Corporate research & development investments international comparisons (1995)Corporate research & developm…Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical Industry (1991)Patent Expiration, Entry, and…Novelty and Disclosure in Patent Law (1990)Novelty and Disclosure in Pat…Market Structure and Innovation: A Reformulation (1980)Market Structure and Innovati…Market Structure and Innovation (1979)Market Structure and Innovati…The Determinants of Industrial Research and Development: A Study of the Chemical, Drug, and Petroleum Industries (1968)The Determinants of Industria…Sustainable Digitalization in Pharmaceutical Supply Chains Using Theory of Constraints: A Qualitative Study (2023)Sustainable Digitalization in…Effects of co-patenting across national boundaries on patent quality. An exploration in pharmaceuticals (2023)Effects of co-patenting acros…Analysis of pharma R&D productivity – a new perspective needed (2023)Analysis of pharma R&D produc…Role of knowledge management processes within different stages of technological innovation: evidence from biotechnology SMEs (2022)Role of knowledge management …Innovation and misconduct in the pharmaceutical industry (2022)Innovation and misconduct in …Exploring How and Why to Develop Patient-Centered Packaging: A Multiple-Case Study with Pharmaceutical Companies (2021)Exploring How and Why to Deve…Resource Allocation Among Competing Innovators (2020)Resource Allocation Among Com…Another look at the instrumental variable estimation of error-components models (1995)Initial conditions and moment restrictions in dynamic panel data models (1998)Econometric Analysis of Cross Section and Panel Data (2001)Fifty Years of Empirical Studies of Innovative Activity and Performance (2010)The productivity crisis in pharmaceutical R&D (2011)Why Working from Home Will Stick (2021)Contingent Valuation: Is Some Number Better than No Number? (1994)Cost-Effectiveness in Health and Medicine (1996)Cost-of-illness studies: concepts, scopes, and methods (2014)Thresholds for the cost–effectiveness of interventions: alternative approaches (2014)Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold (2015)Social Security Bulletin (2018)Principles of Corporate Finance. (1981)Cost of innovation in the pharmaceutical industry (1991)The price of innovation: new estimates of drug development costs (2003)Deconstructing the Drug Development Process: The New Face of Innovation (2010)The cost of drug development: A systematic review (2011)Research and Development Spending to Bring a Single Cancer Drug to Market and Revenues After Approval (2017)The Theory of Monopolistic Competition (1957)Economic Welfare and the Allocation of Resources for Invention (1962)The Private and Social Value of Information and the Reward to Inventive Activity (1978)Uncertainty, Industrial Structure, and the Speed of R and D (1980)The Evolution of New Industries and the Determinants of Market Structure (1990)Innovation and diffusion in small firms: Theory and evidence (1994)On the Complex Economics of Patent Scope (1990)Optimal Patent Length and Breadth (1990)Standing on the Shoulders of Giants: Cumulative Research and the Patent Law (1991)The Economics of Patents: Lessons from Recent U.S. Patent Reform (2002)Sequential innovation, patents, and imitation (2009)Platform Ecosystems: How Developers Invert the Firm1 (2017)The Theory of Business Strategy (1989)How Broad Should the Scope of Patent Protection Be? (1990)Do Stronger Patents Induce More Innovation? Evidence from the 1988 Japanese Patent Law Reforms (2001)Little Patents and Big Secrets: Managing Intellectual Property (2004)Mental Accounting and Consumer Choice (1985)Fairness as a Constraint on Profit Seeking: Entitlements in the Market (2000)Mental Accounting and Consumer Choice (2008)The high price of anticancer drugs: origins, implications, barriers, solutions (2017)Financial toxicity in cancer care: Prevalence, causes, consequences, and reduction strategies (2019)How Much Does It Cost to Research and Develop a New Drug? A Systematic Review and Assessment (2021)Chapter 18 Empirical studies of innovation and market structure (1989)INNOVATION, TECHNOLOGICAL OPPORTUNITY, AND MARKET STRUCTURE (1990)Identifying Technology Spillovers and Product Market Rivalry (2007)American Society of Clinical Oncology Guidance Statement: The Cost of Cancer Care (2009)The Burden of Knowledge and the “Death of the Renaissance Man”: Is Innovation Getting Harder? (2008)
this work references cited by second hop

References

  • 1996Scale, Scope, and Spillovers: The Determinants of Research Productivity in Drug Discovery1,389 cited
  • 1979Market Structure and Innovation1,202 cited
  • 2004Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry971 cited
  • 2006Estimating The Cost Of New Drug Development: Is It Really $802 Million?906 cited
  • 2000Willingness to Pay for a Quality-adjusted Life Year849 cited
  • 1980Market Structure and Innovation: A Reformulation721 cited
  • 1995On the Division of Profit in Sequential Innovation691 cited
  • 2007The cost of biopharmaceutical R&D: is biotech different?517 cited
  • 2015Pricing in the Market for Anticancer Drugs452 cited
  • 1990Novelty and Disclosure in Patent Law433 cited
  • 1991Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical Industry399 cited
  • 1995Corporate research & development investments international comparisons387 cited
  • 2004Static and Dynamic Effects of Health Policy: Evidence from the Vaccine Industry323 cited
  • 1968The Determinants of Industrial Research and Development: A Study of the Chemical, Drug, and Petroleum Industries307 cited
  • 2015Do Firms Underinvest in Long-Term Research? Evidence from Cancer Clinical Trials

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

307 cited
  • 1999The Role of Firm Size in Bilateral Bargaining: A Study of the Cable Television Industry301 cited
  • Cited by

    • 2023Analysis of pharma R&D productivity – a new perspective needed88 cited
    • 2023Sustainable Digitalization in Pharmaceutical Supply Chains Using Theory of Constraints: A Qualitative Study41 cited
    • 2022Role of knowledge management processes within different stages of technological innovation: evidence from biotechnology SMEs33 cited
    • 2020Resource Allocation Among Competing Innovators28 cited
    • 2022Innovation and misconduct in the pharmaceutical industry26 cited
    • 2023Effects of co-patenting across national boundaries on patent quality. An exploration in pharmaceuticals17 cited
    • 2021Exploring How and Why to Develop Patient-Centered Packaging: A Multiple-Case Study with Pharmaceutical Companies10 cited